
Samsung Biologics
company0.0Global Dominance: 0.00%
Samsung Biologics is a South Korean biotechnology company recognized for its rapid growth and investment in large-scale biomanufacturing facilities. Established to provide contract manufacturing services for biopharmaceuticals, the company has emerged as a global leader in the industry, focusing on strategic expansions and partnerships to enhance its market position.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Samsung Biologics is pursuing an acquisition of Polypeptide to strengthen its position in the peptide manufacturing market.
Druck steigt auch auf Lonza und BachemNeue Zürcher Zeitung·
Switzerland· 2026-07-20



